You searched for "snoring"

3017 results found

History of Hearing Device

Alex Griffiths-Brown, BSc(Hons), MRes, Senior Audiologist, The Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK. E: alex.griffiths-brown@nhs.netTwitter: @griffithsbrown1 When I was asked to edit ENT&A Nov/Dec 2023 on the history of hearing devices, I knew it was going to be...

Hearing and balance clinical trials network (HEARING CTN)

About the HEARING CTN The HEARING CTN is a new UK research network focused on promoting research collaboration and supporting high quality research studies, with the aim of improving the evidence supporting the diagnosis and management of hearing loss and...

Where ART meets Science: The Golden Lines of Life

Each cover in this six-part series is more than an image. It’s a window — into a different way of seeing, of hearing and of healing. Together, they form a narrative that moves across disciplines and perspectives. A story told...

Surgical challenges in advanced or recurrent thyroid malignancy

The management of thyroid malignancy and extent of surgery is controversial, especially considering the limitations of preoperative diagnosis. Neil Tolley provides guidance and reminds us of our responsibility not to over-treat. In the UK, 16% of thyroidectomies are performed for...

ENT In This Issue - Identity

Guest Section Editor Katherine Conroy, MA (Cantab) MB BChir FRCS (ORL-HNS), Wythenshawe Hospital, Manchester, UK. Identity is a nebulous concept that has engrossed philosophers since ancient times. It is, at once, how we feel about ourselves and how others perceive...

Extent of central neck dissection in the patients with thyroid carcinoma

The first level of lymphatic spread in well-differentiated thyroid carcinoma is to the central compartment of the neck, namely, the paratracheal, prelaryngeal and pretracheal lymph nodes. Central neck dissection may carry an increased morbidity, namely, hypoparathyroidism and recurrent laryngeal nerve...

Age and vocal cord carcinoma

As the population ages, the management of vocal fold carcinomas should be evaluated. In this retrospective study on 33 patients aged 75 and more, the authors compared the results of radiotherapy and endoscopic treatment for T1 and T2 glottic carcinoma....

In conversation with Shahed Quraishi

Professor Shahed Quraishi OBE. The ENT Masterclass® has been one of the most successful endeavours in ORL education and training in modern times. It has now been around for two decades. To mark the occasion and celebrate a coming of...

Panos Dimitriadis: my experience of the CEORL-HNS

Many of us are invited to ENT conferences throughout the year and, as a trainee, it can sometimes be difficult to decide on which ones will be suitable for our stage in training. In this article, Amir Habeeb interviews Panos...

Panos Dimitriadis: my experience of the CEORL-HNS

Many of us are invited to ENT conferences throughout the year and, as a trainee, it can sometimes be difficult to decide on which ones will be suitable for our stage in training. In this article, Amir Habeeb interviews Panos...

The UK National Eye Health and Hearing Study

A pilot study is currently underway in preparation for a UK National Eye Health and Hearing Study (UKNEHS). This will help to ensure an up-to-date and comprehensive picture of sight and hearing loss among over 50s in the UK.

Immunosuppresants and ototoxicity

There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...